Robin C. Su

Chronic Low Dose Oral Exposure to Microcystin-LR Exacerbates Hepatic Injury in a Murine Model of Non-Alcoholic Fatty Liver Disease

Apurva Lad, Robin C. Su, Joshua D. Breidenbach et al. · Toxins · 2019 · 45 citations · Full text

Exposure to the Harmful Algal Bloom (HAB) Toxin Microcystin-LR (MC-LR) Prolongs and Increases Severity of Dextran Sulfate Sodium (DSS)-Induced Colitis

Robin C. Su, Thomas Blomquist, Andrew L. Kleinhenz et al. · Toxins · 2019 · 39 citations · Full text

Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2)

Kaitlyn Dvorak, Krista M. Pettee, Kaitlin Rubinic-Minotti et al. · PLoS ONE · 2018 · 36 citations · Full text

Breast Oncology, Biological Microenvironments, Pathology +22

Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD)

Robin C. Su, Apurva Lad, Joshua D. Breidenbach et al. · PLoS ONE · 2019 · 31 citations · Full text

Pathology, Fatty Liver Disease, Insulin Signaling +24

Assessment of diagnostic biomarkers of liver injury in the setting of microcystin-LR (MC-LR) hepatotoxicity

Robin C. Su, Apurva Lad, Joshua D. Breidenbach et al. · Chemosphere · 2020 · 31 citations

Hepatology, Liver Injury, Diagnostic Biomarkers +14